Influenza vaccines Vaccine safety data Main navigation COVID-19 vaccines Influenza vaccines 6 months to younger than 5 years 5 years and older (standard vaccines) 60 years and older (adjuvanted or high dose vaccine) Pregnant participants Aboriginal and Torres Strait Islander participants National Immunisation Program schedule vaccines Mpox (monkeypox) vaccine Shingrix® AusVaxSafety commenced routine safety monitoring of 2023 seasonal influenza vaccines used in Australia across all ages in March 2023. The vaccines currently in use are Vaxigrip Tetra®, Fluarix Tetra®, Afluria® Quad (5 years and older), FluQuadri®, Flucelvax® Quad (2 years and older), Influvac® Tetra, Fluad® Quad (65 years and over) and Fluzone® High-Dose Quadrivalent (60 years and over). Surveillance data are provided by AusVaxSafety surveillance tools and are based on vaccine safety surveys sent in the days following influenza vaccination. AusVaxSafety surveillance of 2023 seasonal flu vaccines has concluded with no safety issues identified. Recommencement of surveillance will coincide with the release of 2024 seasonal influenza vaccines. Latest influenza vaccine safety data Click on the tiles below to view 2023 AusVaxSafety influenza vaccine safety data for specific age and population groups. Influenza vaccine safety data - 6 months to younger than 5 years View the latest safety data here Influenza vaccine safety data - 5 years and older (standard vaccines) View the latest safety data here Influenza vaccine safety data - 60 years and older (adjuvanted or high dose vaccine) View the latest safety data here Influenza vaccine safety data - Pregnant participants View the latest safety data here Influenza vaccine safety data - Aboriginal and Torres Strait Islander View the latest safety data here Vaccine safety data Main navigation COVID-19 vaccines Influenza vaccines 6 months to younger than 5 years 5 years and older (standard vaccines) 60 years and older (adjuvanted or high dose vaccine) Pregnant participants Aboriginal and Torres Strait Islander participants National Immunisation Program schedule vaccines Mpox (monkeypox) vaccine Shingrix® News & events All news & events 08 March 2024 | News Vaccine safety in Australia AusVaxSafety summary report now available 20 February 2024 | News What to expect in the days after your XBB.1.5 COVID-19 vaccine 20 December 2023 | News Shingrix® vaccine safety data now available 28 November 2023 | News AusVaxSafety monitoring monovalent Omicron XBB.1.5 variant COVID-19 vaccine safety